University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
NCT Number: NCT03019822
The study will test the effect of dopamine, serotonin, and direct 5-HT2A receptor stimulation on empathy, mood perception, and amygdala activity to fearful stimuli. In addition, we predict associations between subjective effects/alterations in emotion processing tests and functional imaging (fMRI) activity.
Looking for future studies?
Notify Me25 year–50 year
All sexes
Interventional
Early Phase 1
Basel, Canton of Basel-City, 4031, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100ug per os, single dose
Other names: Lysergic Acid Diethylamide
125mg per os, single dose
Other names: 3,4-methylenedioxymethamphetamine
40.3mg per os, single dose
Other names: d-amphetamine sulfate
Capsules containing mannitol looking identical to the other drugs
Time frame: 12 hours
Emotional enhancement (empathy, oxytocin, mood perception, fMRI amygdala blood oxygen level-dependent (BOLD) signal reactivity to fearful stimuli)
Time frame: 1 hour
Associations between subjective effects/alterations in emotion processing with fMRI amygdala BOLD activity
Time frame: 1 hour
Association between emotional enhancement and resting state fMRI neuronal activity
Time frame: 12 hours
Effect modulation by personality traits (assessed with questionnaires), baseline amygdala reactivity to fear in the fMRI, and genetic polymorphisms determined by genotyping of each subject
Time frame: 12 hours
Effect modulation by personality traits (assessed with questionnaires), baseline amygdala reactivity to fear in the fMRI, and genetic polymorphisms determined by genotyping of each subject
Time frame: 12 hours
Effect modulation by personality traits (assessed with questionnaires), baseline amygdala reactivity to fear in the fMRI, and genetic polymorphisms determined by genotyping of each subject
University Hospital, Basel, Switzerland
Other
Acronym: LAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details